These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11874588)

  • 1. How can the cardiac death rate be reduced in dialysis patients?
    Avram MM
    Semin Dial; 2002; 15(1):26-9. PubMed ID: 11874588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperhomocysteinemia in chronic renal failure].
    Sydor A; Sułowicz W
    Przegl Lek; 1999; 56(7-8):520-4. PubMed ID: 10575921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can the cardiac death rate be reduced in dialysis patients?
    Manjunath G; Levey AS; Sarnak MJ
    Semin Dial; 2002; 15(1):18-20. PubMed ID: 11874584
    [No Abstract]   [Full Text] [Related]  

  • 4. How can the cardiac death rate be reduced in dialysis patients?
    Curtis BM; Parfrey PS
    Semin Dial; 2002; 15(1):22-4. PubMed ID: 11874586
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal dialysis for the end-stage renal disease patient with cardiovascular disease.
    Dumler F; McCullough PA
    Adv Chronic Kidney Dis; 2004 Jul; 11(3):261-73. PubMed ID: 15241741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How can the cardiac death rate be reduced in dialysis patients?
    Besarab A
    Semin Dial; 2002; 15(1):24-6. PubMed ID: 11874587
    [No Abstract]   [Full Text] [Related]  

  • 7. Metastatic cardiac calcification in a patient with chronic renal failure who was undergoing hemodialysis: radiographic and CT findings.
    Jing J; Kawashima A; Sickler K; Raval BK; Oldham SA
    AJR Am J Roentgenol; 1998 Apr; 170(4):903-5. PubMed ID: 9530031
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcinosis of the myocardium in chronic haemodialysed patients.
    Zazgornik J; Balcke P; Zyman H
    Pol Arch Med Wewn; 1985 Sep; 74(3):213-6. PubMed ID: 3880321
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of a supplementation with vitamins on cardiovascular morbidity and mortality in patients with end-stage renal disease: design and baseline data of a randomized clinical trial.
    Heinz J; Domröse U; Luley C; Westphal S; Kropf S; Neumann KH; Dierkes J
    Clin Nephrol; 2009 Mar; 71(3):363-5. PubMed ID: 19281755
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renal insufficiency is an important cardiovascular risk factor].
    Pérez Flores I; Luño J
    Nefrologia; 2002; 22(4):306-9. PubMed ID: 12369120
    [No Abstract]   [Full Text] [Related]  

  • 11. New developments in hyperphosphatemia management.
    Slatopolsky E
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S297-9. PubMed ID: 12939384
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperhomocysteinemia as a risk factor for cardiovascular disease in patients undergoing hemodialysis.
    Friedman JA; Dwyer JT
    Nutr Rev; 1995 Jul; 53(7):197-201. PubMed ID: 7494622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
    Martola L; Elinder CG; Stenvinkel P
    Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiovascular burden of end-stage renal disease patients.
    Cianciolo G; Donati G; La Manna G; Ferri A; Cuna V; Ubaldi G; Corsini S; Lanci N; Colì L; Stefoni S
    Minerva Urol Nefrol; 2010 Mar; 62(1):51-66. PubMed ID: 20424570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imaging modalities for evaluation of cardiac function in patients with chronic hemodialysis].
    Komiyama N
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():92-5. PubMed ID: 15250275
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular problems on hemodialysis: current deficits and potential improvement.
    Ritz E; Bommer J
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S71-8. PubMed ID: 19996009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin D, cardiovascular disease and mortality in patients with kidney disease].
    Hansen D; Brandi L; Rasmussen K
    Ugeskr Laeger; 2009 Dec; 171(50):3684-9. PubMed ID: 20003863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic myocardial calcification in chronic renal failure presenting as atrioventricular block.
    Henderson RR; Santiago LM; Spring DA; Harrington AR
    N Engl J Med; 1971 Jun; 284(22):1252-3. PubMed ID: 5573836
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial calcinosis associated with hemodialysis.
    Zazgornik J; Balcke P; Biesenbach G; Kaiser W; Stockenhuber F
    Am J Cardiol; 1987 Aug; 60(4):421-2. PubMed ID: 3618514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.